Lumexa Imaging Hldgs Financials - Benzinga

Lumexa Imaging Holdings Inc

LMRINASDAQ

Trade with Public

Trade with Public

$12.18

0.282.35%

At close: Sep 4, 5:00 PM EST

$12.18

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

Lumexa Imaging Hldgs Financials

Lumexa Imaging Hldgs (LMRI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Lumexa Imaging Holdings Affirms FY2026 Adj EPS Guidance of $0.71-$0.77 vs $0.62 Est; Raises FY2026 Sales Guidance from $1.045B-$1.090B to $1.045B-$1.097B vs $1.067B Est

Lumexa Imaging Holdings (NASDAQ:LMRI) affirms FY2026 Adj EPS guidance from $0.71-$0.77 to $0.71-$0.77 vs $0.62 analyst estimate. Raises FY2026 sales outlook from $1.045 billion-$1.090 billion to $1.045 billion-$1.097

Benzinga Newsdesk

PRO
Lumexa Imaging Holdings Q2 Adj. EPS $0.20 Beats $0.16 Estimate, Sales $264.200M Beat $263.113M Estimate

Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.16 by 25 percent. The company reported quarterly sales of $264.200 million which beat

Benzinga Newsdesk

PRO
Lumexa Imaging Holdings Sees FY2026 Adj EPS $0.71-$0.77 vs $0.73 Est; Narrows FY2026 Sales Guidance from $1.045B-$1.097B to $1.045B-$1.090B vs $1.067B Est

Lumexa Imaging Holdings (NASDAQ:LMRI) is looking for FY2026 Adj EPS of $0.71-$0.77 vs $0.73 analyst estimate. Narrows FY2026 sales outlook from $1.045 billion-$1.097 billion to $1.045 billion-$1.090 billion vs $1.067

Benzinga Newsdesk

PRO
Lumexa Imaging Holdings Q1 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $252.500M Beat $251.004M Estimate

Lumexa Imaging Holdings (NASDAQ:LMRI) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.12 by 50 percent. The company reported quarterly sales of $252.500 million which beat

Benzinga Newsdesk

Earnings Scheduled For May 12, 2026

Benzinga Insights

PRO
Lumexa Imaging Reiterates FY 2026 Guidance

On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.The information furnished pursuant to Item

Benzinga Newsdesk